![]() |

![]() |
Create Name: | |
Description: |
![]() |
Save what matters to you |
{{ loginError }} |
Sign in with your RGD account |
Create New Account | Recover Password |
Analyze GeneStrainQTL List |
![]() Gene Annotator (Functional Annotation) unavailable |
![]() Gene Annotator (Annotation Distribution) unavailable |
![]() Variant Visualizer (Genomic Variants) unavailble Variant Visualizer (Genomic Variants) unavailable |
Gene Annotator (Functional Annotation) |
Gene Annotator (Annotation Distribution) |
Variant Visualizer (Genomic Variants) |
![]() InterViewer (Protein-Protein Interactions) unavailable |
![]() Gviewer (Genome Viewer) unavailable |
![]() Variant Visualizer (Damaging Variants) unavailble Variant Visualizer (Damaging Variants) unavailable |
InterViewer (Protein-Protein Interactions) |
GViewer (Genome Viewer) |
Variant Visualizer (Damaging Variants) |
![]() Gene Annotator (Annotation Comparison) unavailable |
![]() OLGA (Gene List Generator) unavailable |
![]() |
Gene Annotator (Annotation Comparison) |
OLGA (Gene List Generator) |
Excel (Download) |
![]() MOET (Multi-Ontology Enrichement) unavailable |
![]() GOLF (Gene-Ortholog Location Finder) unavailable |
|
MOET (Multi-Ontology Enrichement) |
GOLF (Gene-Ortholog Location Finder) |
![]() Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | 17beta-estradiol | multiple interactions | EXP | | 6480464 | [Estradiol co-treated with Progesterone] results in decreased expression of BAALC mRNA | CTD | PMID:20660070 | 17beta-estradiol 3-benzoate | increases methylation | ISO | RGD:628703 | 6480464 | estradiol 3-benzoate results in increased methylation of BAALC promoter | CTD | PMID:27415467 | aflatoxin B1 | decreases methylation | EXP | | 6480464 | Aflatoxin B1 results in decreased methylation of BAALC gene | CTD | PMID:27153756 | all-trans-retinoic acid | increases expression | EXP | | 6480464 | Tretinoin results in increased expression of BAALC mRNA | CTD | PMID:21934132, PMID:23724009 | arsane | affects methylation | EXP | | 6480464 | Arsenic affects the methylation of BAALC gene | CTD | PMID:25304211 | arsenic atom | affects methylation | EXP | | 6480464 | Arsenic affects the methylation of BAALC gene | CTD | PMID:25304211 | arsenous acid | decreases expression | EXP | | 6480464 | Arsenic Trioxide results in decreased expression of BAALC mRNA | CTD | PMID:19128835, PMID:26705709 | bisphenol A | affects expression | ISO | RGD:628703 | 6480464 | bisphenol A affects the expression of BAALC mRNA | CTD | PMID:25181051 | bisphenol A | affects methylation | ISO | RGD:628703 | 6480464 | bisphenol A affects the methylation of BAALC promoter | CTD | PMID:27415467 | carbamazepine | affects expression | EXP | | 6480464 | Carbamazepine affects the expression of BAALC mRNA | CTD | PMID:25979313 | carbon nanotube | increases expression | ISO | RGD:733883 | 6480464 | Nanotubes, Carbon results in increased expression of BAALC mRNA | CTD | PMID:25554681 | chlorpyrifos | increases expression | ISO | RGD:628703 | 6480464 | Chlorpyrifos results in increased expression of BAALC mRNA | CTD | PMID:18668222 | cocaine | decreases expression | ISO | RGD:733883 | 6480464 | Cocaine results in decreased expression of BAALC mRNA | CTD | PMID:18355967 | diarsenic trioxide | decreases expression | EXP | | 6480464 | Arsenic Trioxide results in decreased expression of BAALC mRNA | CTD | PMID:19128835, PMID:26705709 | dorsomorphin | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | doxorubicin | decreases expression | EXP | | 6480464 | Doxorubicin results in decreased expression of BAALC mRNA | CTD | PMID:29803840 | entinostat | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of BAALC mRNA | CTD | PMID:27188386 | entinostat | decreases expression | EXP | | 6480464 | entinostat results in decreased expression of BAALC mRNA | CTD | PMID:26272509 | ethanol | increases expression | ISO | RGD:733883 | 6480464 | Ethanol results in increased expression of BAALC mRNA | CTD | PMID:30319688 | furan | increases expression | ISO | RGD:628703 | 6480464 | furan results in increased expression of BAALC mRNA | CTD | PMID:27387713 | lead(0) | affects expression | EXP | | 6480464 | Lead affects the expression of BAALC mRNA | CTD | PMID:28903495 | lead(2+) | affects expression | EXP | | 6480464 | Lead affects the expression of BAALC mRNA | CTD | PMID:28903495 | methylmercury chloride | decreases expression | EXP | | 6480464 | methylmercuric chloride results in decreased expression of BAALC mRNA | CTD | PMID:28001369 | progesterone | multiple interactions | EXP | | 6480464 | [Estradiol co-treated with Progesterone] results in decreased expression of BAALC mRNA | CTD | PMID:20660070 | SB 431542 | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | titanium dioxide | increases expression | ISO | RGD:628703 | 6480464 | titanium dioxide results in increased expression of BAALC mRNA | CTD | PMID:30012374 | trichostatin A | decreases expression | EXP | | 6480464 | trichostatin A results in decreased expression of BAALC mRNA | CTD | PMID:24935251, PMID:26272509 | trichostatin A | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of BAALC mRNA | CTD | PMID:27188386 | uranium atom | affects expression | EXP | | 6480464 | Uranium affects the expression of BAALC mRNA | CTD | PMID:15672453 | valproic acid | decreases methylation | EXP | | 6480464 | Valproic Acid results in decreased methylation of BAALC gene | CTD | PMID:29154799 | valproic acid | affects expression | EXP | | 6480464 | Valproic Acid affects the expression of BAALC mRNA | CTD | PMID:25979313 | valproic acid | increases expression | EXP | | 6480464 | Valproic Acid results in increased expression of BAALC mRNA | CTD | PMID:19101580 more ... | |
|
|
|
|
|
|
|
1. | RGD automated import pipeline for gene-chemical interactions |
2. | Tanner SM, etal., Proc Natl Acad Sci U S A 2001 Nov 20;98(24):13901-6. |
PubMed | 12477932 14702039 15489334 15604894 15749074 16189514 17646667 18029348 18378853 18671757 18752846 19555438 19943049 20065290 20306678 20495894 20535151 20841507 21835957 21873635 21967978 22197554 22488406 22493267 22529287 23275563 23287429 23647058 23672350 23760853 23865362 24736457 24855032 25428390 25640309 26012361 26050649 26430723 26625814 27372260 27662611 29696374 |
BAALC (Homo sapiens - human) |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Baalc (Mus musculus - house mouse) |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Baalc (Rattus norvegicus - Norway rat) |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Baalc (Chinchilla lanigera - long-tailed chinchilla) |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
BAALC (Pan paniscus - bonobo/pygmy chimpanzee) |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
BAALC (Canis lupus familiaris - dog) |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Baalc (Ictidomys tridecemlineatus - thirteen-lined ground squirrel) |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
BAALC (Sus scrofa - pig) |
|
RH98648 |
|
||||||||||||||||||||||||||||||||||||||||
RH103102 |
|
||||||||||||||||||||||||||||||||||||||||
RH120941 |
|
||||||||||||||||||||||||||||||||||||||||
G62950 |
|
||||||||||||||||||||||||||||||||||||||||
D8S1692 |
|
||||||||||||||||||||||||||||||||||||||||
SHGC-147735 |
|
||||||||||||||||||||||||||||||||||||||||
D8S1977 |
|
||||||||||||||||||||||||||||||||||||||||
STS-AA018831 |
|
||||||||||||||||||||||||||||||||||||||||
D8S1390E |
|
The detailed report is available here: | ![]() | Full Report | ![]() | CSV | ![]() | TAB | ![]() | Printer |
miRNA Target Status data imported from miRGate (http://mirgate.bioinfo.cnio.es/). For more information about miRGate, see PMID:25858286 or access the full paper here. |
RefSeq Transcripts | NM_001024372 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles |
NM_001364874 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles | |
NM_024812 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles | |
XR_001745601 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles | |
GenBank Nucleotide | AC025370 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles |
AF363578 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles | |
AF371319 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles | |
AF371323 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles | |
AK022077 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles | |
AK093819 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles | |
AK310816 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles | |
AP003550 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles | |
BC011517 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles | |
BC014365 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles | |
BC035038 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles | |
BI548687 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles | |
BI602606 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles | |
CH471060 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles |
RefSeq Acc Id: | NM_001024372 ⟹ NP_001019543 | |||||||||||||||||||||||||||||
RefSeq Status: | REVIEWED | |||||||||||||||||||||||||||||
Type: | CODING | |||||||||||||||||||||||||||||
Position: |
|
|||||||||||||||||||||||||||||
Sequence: |
GCGGAGAGGAGGGACGGGCTGGGAGAGGGCCCGGACTAGGGGCGGCGGGCACCGCAGGAGCTCChide sequence |
RefSeq Acc Id: | NM_001364874 ⟹ NP_001351803 | |||||||||
RefSeq Status: | REVIEWED | |||||||||
Type: | CODING | |||||||||
Position: |
|
RefSeq Acc Id: | NM_024812 ⟹ NP_079088 | |||||||||||||||||||||||||||||
RefSeq Status: | REVIEWED | |||||||||||||||||||||||||||||
Type: | CODING | |||||||||||||||||||||||||||||
Position: |
|
|||||||||||||||||||||||||||||
Sequence: |
GCGGAGAGGAGGGACGGGCTGGGAGAGGGCCCGGACTAGGGGCGGCGGGCACCGCAGGAGCTCChide sequence |
RefSeq Acc Id: | XR_001745601 | |||||||||
RefSeq Status: | ||||||||||
Type: | NON-CODING | |||||||||
Position: |
|
|||||||||
Sequence: |
AGGAGCTCCGCGCGGCTGCAGCGCGGGCGGGAGCGGGGACGCGATGTCGCCGCCGCCGCCTCCThide sequence |
Protein RefSeqs | NP_001019543 | (Get FASTA) | NCBI Sequence Viewer |
NP_001351803 | (Get FASTA) | NCBI Sequence Viewer | |
NP_079088 | (Get FASTA) | NCBI Sequence Viewer | |
GenBank Protein | AAH11517 | (Get FASTA) | NCBI Sequence Viewer |
AAH35038 | (Get FASTA) | NCBI Sequence Viewer | |
AAL50377 | (Get FASTA) | NCBI Sequence Viewer | |
AAL50378 | (Get FASTA) | NCBI Sequence Viewer | |
AAL50379 | (Get FASTA) | NCBI Sequence Viewer | |
AAL50380 | (Get FASTA) | NCBI Sequence Viewer | |
AAL50381 | (Get FASTA) | NCBI Sequence Viewer | |
AAL50382 | (Get FASTA) | NCBI Sequence Viewer | |
AAL50515 | (Get FASTA) | NCBI Sequence Viewer | |
AAL50519 | (Get FASTA) | NCBI Sequence Viewer | |
BAB13960 | (Get FASTA) | NCBI Sequence Viewer | |
EAW91862 | (Get FASTA) | NCBI Sequence Viewer | |
EAW91863 | (Get FASTA) | NCBI Sequence Viewer | |
EAW91864 | (Get FASTA) | NCBI Sequence Viewer | |
EAW91865 | (Get FASTA) | NCBI Sequence Viewer | |
Q8WXS3 | (Get FASTA) | NCBI Sequence Viewer |
RefSeq Acc Id: | NP_079088 ⟸ NM_024812 |
- Peptide Label: | isoform 1 |
- UniProtKB: | Q8WXS3 (UniProtKB/Swiss-Prot) |
- Sequence: |
MGCGGSRADAIEPRYYESWTRETESTWLTYTDSDAPPSAAAPDSGPEAGGLHSGMLEDGLPSNGhide sequence |
RefSeq Acc Id: | NP_001019543 ⟸ NM_001024372 |
- Peptide Label: | isoform 2 |
- UniProtKB: | Q8WXS3 (UniProtKB/Swiss-Prot) |
- Sequence: |
MGCGGSRADAIEPRYYESWTRETESTWLTYTDSDAPPSAAAPDSGPEAGGLHSGhide sequence |
RefSeq Acc Id: | NP_001351803 ⟸ NM_001364874 |
- Peptide Label: | isoform 3 |
RGD ID: | 7213941 | |||||||||
Promoter ID: | EPDNEW_H12715 | |||||||||
Type: | initiation region | |||||||||
Name: | BAALC_1 | |||||||||
Description: | brain and acute leukemia, cytoplasmic | |||||||||
SO ACC ID: | SO:0000170 | |||||||||
Source: | EPDNEW (Eukaryotic Promoter Database, http://epd.vital-it.ch/) | |||||||||
Experiment Methods: | Single-end sequencing. | |||||||||
Position: |
|
Name | Type | Condition(s) | Position(s) | Clinical significance |
GRCh38/hg38 8q22.3(chr8:101962098-103357772)x3 | copy number gain | Global developmental delay [RCV000050760]|See cases [RCV000050760] | Chr8:101962098..103357772 [GRCh38] Chr8:102974326..104370000 [GRCh37] Chr8:103043502..104439176 [NCBI36] Chr8:8q22.3 |
pathogenic |
GRCh38/hg38 8p23.3-q24.3(chr8:241530-145049449)x3 | copy number gain | Seizures [RCV000051206]|See cases [RCV000051206] | Chr8:241530..145049449 [GRCh38] Chr8:191530..146274835 [GRCh37] Chr8:181530..146245639 [NCBI36] Chr8:8p23.3-q24.3 |
pathogenic |
GRCh38/hg38 8q22.1-24.3(chr8:95606052-145054775)x3 | copy number gain | Developmental Delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000053677]|Developmental delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000053677]|See cases [RCV000053677] | Chr8:95606052..145054775 [GRCh38] Chr8:96618280..146280161 [GRCh37] Chr8:96687456..146250965 [NCBI36] Chr8:8q22.1-24.3 |
pathogenic |
GRCh38/hg38 8p23.3-q24.3(chr8:241530-145054634)x3 | copy number gain | Developmental Delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000053602]|Developmental delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000053602]|See cases [RCV000053602] | Chr8:241530..145054634 [GRCh38] Chr8:191530..146280020 [GRCh37] Chr8:181530..146250824 [NCBI36] Chr8:8p23.3-q24.3 |
pathogenic |
GRCh38/hg38 8p23.3-q24.3(chr8:244417-145054775)x3 | copy number gain | Developmental Delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000053604]|Developmental delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000053604]|See cases [RCV000053604] | Chr8:244417..145054775 [GRCh38] Chr8:194417..146280161 [GRCh37] Chr8:184417..146250965 [NCBI36] Chr8:8p23.3-q24.3 |
pathogenic |
GRCh38/hg38 8q22.1-24.3(chr8:94682154-145068656)x3 | copy number gain | See cases [RCV000134353] | Chr8:94682154..145068656 [GRCh38] Chr8:95694382..146294042 [GRCh37] Chr8:95763558..146264846 [NCBI36] Chr8:8q22.1-24.3 |
pathogenic |
GRCh38/hg38 8q22.3-23.1(chr8:101884819-107356143)x1 | copy number loss | See cases [RCV000134099] | Chr8:101884819..107356143 [GRCh38] Chr8:102897047..108368371 [GRCh37] Chr8:102966223..108437547 [NCBI36] Chr8:8q22.3-23.1 |
pathogenic |
GRCh38/hg38 8q21.3-24.23(chr8:86300584-137022587)x3 | copy number gain | See cases [RCV000135621] | Chr8:86300584..137022587 [GRCh38] Chr8:87312813..138034830 [GRCh37] Chr8:87381929..138104012 [NCBI36] Chr8:8q21.3-24.23 |
pathogenic|likely pathogenic |
GRCh38/hg38 8q22.3-23.1(chr8:101199826-105802098)x1 | copy number loss | See cases [RCV000136812] | Chr8:101199826..105802098 [GRCh38] Chr8:102212054..106814326 [GRCh37] Chr8:102281230..106883502 [NCBI36] Chr8:8q22.3-23.1 |
pathogenic |
GRCh38/hg38 8q22.3-23.1(chr8:101171263-109127664)x1 | copy number loss | See cases [RCV000138134] | Chr8:101171263..109127664 [GRCh38] Chr8:102183491..110139893 [GRCh37] Chr8:102252667..110209069 [NCBI36] Chr8:8q22.3-23.1 |
pathogenic |
GRCh38/hg38 8p23.3-q24.3(chr8:241605-145054781)x3 | copy number gain | See cases [RCV000138643] | Chr8:241605..145054781 [GRCh38] Chr8:191605..146280167 [GRCh37] Chr8:181605..146250971 [NCBI36] Chr8:8p23.3-q24.3 |
pathogenic |
GRCh38/hg38 8q21.3-24.3(chr8:87931152-145068712)x3 | copy number gain | See cases [RCV000138551] | Chr8:87931152..145068712 [GRCh38] Chr8:88943380..146294098 [GRCh37] Chr8:89012496..146264902 [NCBI36] Chr8:8q21.3-24.3 |
pathogenic |
GRCh38/hg38 8q21.13-24.3(chr8:77480050-145068712)x3 | copy number gain | See cases [RCV000139036] | Chr8:77480050..145068712 [GRCh38] Chr8:78392286..146294098 [GRCh37] Chr8:78554841..146264902 [NCBI36] Chr8:8q21.13-24.3 |
pathogenic |
GRCh38/hg38 8q22.1-24.3(chr8:97382873-145070385)x3 | copy number gain | See cases [RCV000140447] | Chr8:97382873..145070385 [GRCh38] Chr8:98395101..146295771 [GRCh37] Chr8:98464277..146266575 [NCBI36] Chr8:8q22.1-24.3 |
pathogenic |
GRCh38/hg38 8q11.1-24.3(chr8:46031340-139285494)x3 | copy number gain | See cases [RCV000139539] | Chr8:46031340..139285494 [GRCh38] Chr8:46942962..140297737 [GRCh37] Chr8:47062127..140366919 [NCBI36] Chr8:8q11.1-24.3 |
pathogenic |
GRCh38/hg38 8p23.3-q24.3(chr8:208048-145070385)x3 | copy number gain | See cases [RCV000141808] | Chr8:208048..145070385 [GRCh38] Chr8:158048..146295771 [GRCh37] Chr8:148048..146266575 [NCBI36] Chr8:8p23.3-q24.3 |
pathogenic |
GRCh38/hg38 8q22.3-24.3(chr8:100867343-145070385)x3 | copy number gain | See cases [RCV000141694] | Chr8:100867343..145070385 [GRCh38] Chr8:101879571..146295771 [GRCh37] Chr8:101948747..146266575 [NCBI36] Chr8:8q22.3-24.3 |
pathogenic |
GRCh38/hg38 8q22.2-23.1(chr8:100179408-106524667)x1 | copy number loss | See cases [RCV000141697] | Chr8:100179408..106524667 [GRCh38] Chr8:101191636..107536895 [GRCh37] Chr8:101260812..107606071 [NCBI36] Chr8:8q22.2-23.1 |
pathogenic |
GRCh38/hg38 8p21.3-q24.3(chr8:21291522-145070385)x3 | copy number gain | See cases [RCV000142021] | Chr8:21291522..145070385 [GRCh38] Chr8:21149033..146295771 [GRCh37] Chr8:21193313..146266575 [NCBI36] Chr8:8p21.3-q24.3 |
pathogenic |
GRCh38/hg38 8p23.3-q24.3(chr8:226452-145068712)x3 | copy number gain | See cases [RCV000142858] | Chr8:226452..145068712 [GRCh38] Chr8:176452..146294098 [GRCh37] Chr8:166452..146264902 [NCBI36] Chr8:8p23.3-q24.3 |
pathogenic |
GRCh38/hg38 8q21.13-24.3(chr8:78614077-145054634)x3 | copy number gain | See cases [RCV000142597] | Chr8:78614077..145054634 [GRCh38] Chr8:79526312..146280020 [GRCh37] Chr8:79688867..146250824 [NCBI36] Chr8:8q21.13-24.3 |
pathogenic |
GRCh38/hg38 8p23.3-q24.3(chr8:241530-145054634)x3 | copy number gain | See cases [RCV000148092] | Chr8:241530..145054634 [GRCh38] Chr8:191530..146280020 [GRCh37] Chr8:181530..146250824 [NCBI36] Chr8:8p23.3-q24.3 |
pathogenic |
GRCh38/hg38 8q21.2-24.3(chr8:85765999-145070385)x3 | copy number gain | See cases [RCV000143659] | Chr8:85765999..145070385 [GRCh38] Chr8:86778228..146295771 [GRCh37] Chr8:86863079..146266575 [NCBI36] Chr8:8q21.2-24.3 |
pathogenic |
GRCh37/hg19 8p23.3-q24.3(chr8:158991-146280828)x3 | copy number gain | See cases [RCV000447507] | Chr8:158991..146280828 [GRCh37] Chr8:8p23.3-q24.3 |
pathogenic |
GRCh37/hg19 8q22.1-24.3(chr8:98432250-146222672)x4 | copy number gain | See cases [RCV000448954] | Chr8:98432250..146222672 [GRCh37] Chr8:8q22.1-24.3 |
pathogenic |
GRCh37/hg19 8p23.3-q24.3(chr8:158049-146295771) | copy number gain | See cases [RCV000510234] | Chr8:158049..146295771 [GRCh37] Chr8:8p23.3-q24.3 |
pathogenic |
GRCh37/hg19 8q21.3-24.3(chr8:93047482-141355635)x3 | copy number gain | See cases [RCV000511761] | Chr8:93047482..141355635 [GRCh37] Chr8:8q21.3-24.3 |
pathogenic |
GRCh37/hg19 8p23.3-q24.3(chr8:158049-146295771)x3 | copy number gain | See cases [RCV000511095] | Chr8:158049..146295771 [GRCh37] Chr8:8p23.3-q24.3 |
pathogenic |
GRCh37/hg19 8q21.2-24.3(chr8:86841154-146295771)x3 | copy number gain | See cases [RCV000511002] | Chr8:86841154..146295771 [GRCh37] Chr8:8q21.2-24.3 |
pathogenic |
GRCh37/hg19 8q21.2-24.3(chr8:86841228-142689874)x3 | copy number gain | See cases [RCV000510854] | Chr8:86841228..142689874 [GRCh37] Chr8:8q21.2-24.3 |
pathogenic |
GRCh37/hg19 8p23.1-q24.3(chr8:12490999-146295771)x3 | copy number gain | See cases [RCV000512169] | Chr8:12490999..146295771 [GRCh37] Chr8:8p23.1-q24.3 |
pathogenic |
GRCh37/hg19 8q22.3(chr8:102584167-104236192)x1 | copy number loss | not provided [RCV000683013] | Chr8:102584167..104236192 [GRCh37] Chr8:8q22.3 |
likely pathogenic |
GRCh37/hg19 8q21.2-23.3(chr8:86841154-116518125)x3 | copy number gain | not provided [RCV000683045] | Chr8:86841154..116518125 [GRCh37] Chr8:8q21.2-23.3 |
pathogenic |
GRCh37/hg19 8q22.3(chr8:104221791-104770147)x3 | copy number gain | not provided [RCV000682982] | Chr8:104221791..104770147 [GRCh37] Chr8:8q22.3 |
uncertain significance |
GRCh37/hg19 8p23.3-q24.3(chr8:10213-146293414)x3 | copy number gain | not provided [RCV000747248] | Chr8:10213..146293414 [GRCh37] Chr8:8p23.3-q24.3 |
pathogenic |
GRCh37/hg19 8p23.3-q24.3(chr8:164984-146293414)x3 | copy number gain | not provided [RCV000747254] | Chr8:164984..146293414 [GRCh37] Chr8:8p23.3-q24.3 |
pathogenic |
GRCh37/hg19 8q22.3(chr8:103950997-104487840)x3 | copy number gain | not provided [RCV000747746] | Chr8:103950997..104487840 [GRCh37] Chr8:8q22.3 |
benign |
GRCh37/hg19 8p12-q24.3(chr8:31936551-146295771)x3 | copy number gain | not provided [RCV000848192] | Chr8:31936551..146295771 [GRCh37] Chr8:8p12-q24.3 |
pathogenic |
GRCh37/hg19 8p23.3-q24.3(chr8:158048-146295771)x3 | copy number gain | not provided [RCV000848478] | Chr8:158048..146295771 [GRCh37] Chr8:8p23.3-q24.3 |
pathogenic |
Database | Acc Id | Source(s) |
AGR Gene | HGNC:14333 | AgrOrtholog |
COSMIC | BAALC | COSMIC |
Ensembl Genes | ENSG00000164929 | ENTREZGENE, UniProtKB/Swiss-Prot |
Ensembl Protein | ENSP00000297574 | ENTREZGENE, UniProtKB/Swiss-Prot |
ENSP00000302559 | UniProtKB/Swiss-Prot | |
ENSP00000312457 | ENTREZGENE, UniProtKB/Swiss-Prot | |
ENSP00000331579 | UniProtKB/Swiss-Prot | |
ENSP00000395024 | ENTREZGENE, UniProtKB/Swiss-Prot | |
Ensembl Transcript | ENST00000297574 | ENTREZGENE, UniProtKB/Swiss-Prot |
ENST00000306391 | UniProtKB/Swiss-Prot | |
ENST00000309982 | ENTREZGENE, UniProtKB/Swiss-Prot | |
ENST00000330955 | UniProtKB/Swiss-Prot | |
ENST00000438105 | ENTREZGENE, UniProtKB/Swiss-Prot | |
GTEx | ENSG00000164929 | GTEx |
HGNC ID | HGNC:14333 | ENTREZGENE |
Human Proteome Map | BAALC | Human Proteome Map |
InterPro | BAALC | UniProtKB/Swiss-Prot |
KEGG Report | hsa:79870 | UniProtKB/Swiss-Prot |
NCBI Gene | 79870 | ENTREZGENE |
OMIM | 606602 | OMIM |
PANTHER | PTHR14731 | UniProtKB/Swiss-Prot |
Pfam | BAALC_N | UniProtKB/Swiss-Prot |
PharmGKB | PA25230 | PharmGKB |
UniGene | Hs.533446 | ENTREZGENE |
UniProt | BAALC_HUMAN | UniProtKB/Swiss-Prot, ENTREZGENE |
UniProt Secondary | Q8WTP6 | UniProtKB/Swiss-Prot |
Q8WXS0 | UniProtKB/Swiss-Prot | |
Q8WXS1 | UniProtKB/Swiss-Prot | |
Q8WXS2 | UniProtKB/Swiss-Prot | |
Q9HA93 | UniProtKB/Swiss-Prot |
Date | Current Symbol | Current Name | Previous Symbol | Previous Name | Description | Reference | Status |
---|---|---|---|---|---|---|---|
2019-01-29 | BAALC | BAALC binder of MAP3K1 and KLF4 | BAALC, MAP3K1 and KLF4 binding | Symbol and/or name change | 5135510 | APPROVED | |
2017-05-16 | BAALC | BAALC, MAP3K1 and KLF4 binding | brain and acute leukemia, cytoplasmic | Symbol and/or name change | 5135510 | APPROVED | |
2011-08-17 | BAALC | brain and acute leukemia, cytoplasmic | BAALC | brain and acute leukemia, cytoplasmic | Symbol and/or name change | 5135510 | APPROVED |
![]() |
More on BAALC | |
![]() |
Alliance Gene |
![]() |
NCBI Gene |
![]() |
Ensembl Gene |
![]() |
JBrowse: hg19 hg38 |
![]() |
HGNC Report |
![]() |
NCBI Genome Data Viewer |
CRRD Object Information | |
CRRD ID: | 736795 |
Created: | 2004-02-06 |
Species: | Homo sapiens |
Last Modified: | 2019-11-26 |
Status: | ACTIVE |
![]() |
![]() |
![]() |
![]() |
RGD is funded by grant HL64541 from the National Heart, Lung, and Blood Institute on behalf of the NIH.